mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.06 |
0.06 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.06 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.07 |